Hisamitsu Pharmaceutical Co Inc stock PB Ratio (=0.96) is close to 10-year low of 0.96.
The historical rank and industry rank for Hisamitsu Pharmaceutical Co's PB Ratio or its related term are showing as below:
FSE:4530'
s PB Ratio Range Over the Past 10 Years
Min: 0.96 Med: 1.53 Max: 2.94
Current: 0.96
During the past 13 years, Hisamitsu Pharmaceutical Co's highest PB Ratio was 2.94. The lowest was 0.96. And the median was 1.53.
FSE:4530's PB Ratio is ranked better than 76.57% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.825
vs FSE:4530: 0.96
During the past 12 months, Hisamitsu Pharmaceutical Co's average Book Value Per Share Growth Rate was 9.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 7.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 4.00% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Hisamitsu Pharmaceutical Co was 14.20% per year. The lowest was 1.90% per year. And the median was 7.50% per year.
Back to Basics: PB Ratio
Hisamitsu Pharmaceutical Co (FSE:4530) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hisamitsu Pharmaceutical Co PB Ratio Related Terms
Hisamitsu Pharmaceutical Co PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hisamitsu Pharmaceutical Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hisamitsu Pharmaceutical Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hisamitsu Pharmaceutical Co (FSE:4530) has a PB Ratio of 0.96 as of Jun. 26, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hisamitsu Pharmaceutical Co and its competitors. This is 37% below median its historical median of 1.53. Over the past decade, Hisamitsu Pharmaceutical Co's PB Ratio has ranged from 0.96 to 2.94. According to the industry distribution chart, Hisamitsu Pharmaceutical Co ranks #216 out of 922 companies in the Drug Manufacturers industry, placing it in the top 23.4%.
Is Hisamitsu Pharmaceutical Co's PB Ratio too high?
Hisamitsu Pharmaceutical Co's current PB Ratio of 0.96 is 37% below median its 10-year median of 1.53. Over the past 10 years, this metric has ranged from a low of 0.96 to a high of 2.94. The Drug Manufacturers industry median PB Ratio is 1.83. Hisamitsu Pharmaceutical Co's value of 0.96 is 47.4% below this industry median. Based on the distribution chart, Hisamitsu Pharmaceutical Co ranks #216 out of 922 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Hisamitsu Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Hisamitsu Pharmaceutical Co's PB Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Hisamitsu Pharmaceutical Co ranks #216 out of 922 companies for PB Ratio. This places Hisamitsu Pharmaceutical Co in the top 23% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.83. Hisamitsu Pharmaceutical Co's value of 0.96 is 47.4% below this benchmark. Historically, Hisamitsu Pharmaceutical Co's own PB Ratio has ranged from 0.96 to 2.94 over the past decade. While the company's 10-year median is 1.53 vs. the industry median of 1.83, Hisamitsu Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.83, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hisamitsu Pharmaceutical Co's current PB Ratio of 0.96 is 47.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hisamitsu Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hisamitsu Pharmaceutical Co's current PB Ratio is 0.96, which is 37% below median its own 10-year median of 1.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hisamitsu Pharmaceutical Co stock overvalued right now?
Hisamitsu Pharmaceutical Co (FSE:4530) has a current PB Ratio of 0.96. The stock's GF Value™ is 円3,237.07, compared to a current price of 円3,975.00 — trading 22.8% above its estimated fair value. The current PB Ratio is 0.96, which is 37% below median its 10-year median of 1.53 and 47.4% below the Drug Manufacturers industry median of 1.83. Hisamitsu Pharmaceutical Co's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hisamitsu Pharmaceutical Co (FSE:4530), the current PB Ratio is 0.96 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hisamitsu Pharmaceutical Co (FSE:4530) Overvalued in 2026?
Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円3,975.00 is trading 22.8% above its estimated GF Value™ of 円3,237.07.
Key valuation signals for FSE:4530:
PB Ratio: 0.96 (37% below median its 10-year median of 1.53)
GF Value™: 円3,237.07 vs. price of 円3,975.00 (22.8% above fair value)
Industry Position: 47.4% below the Drug Manufacturers median (#216 of 922)
No single metric tells the full story. See the FSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
89GF Score
Get the complete analysis for FSE:4530
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FSE:4530 has been successfully added to your 
